WallStreetZenWallStreetZen

NASDAQ: CTOR
Citius Oncology Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Citius Oncology revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, CTOR annual revenue was $0.0, with N/A growth year-over-year.

CTOR revenue history

Current Revenue
$0.0
Current Earnings
-$17.8M
Current Profit Margin
0%

Be the first to know when CTOR announces revenue.

CTOR Revenue History By Year

CTOR Yearly RevenueCTOR RevenueCTOR ChangeCTOR Revenue Growth
2024-09-30$0.00N/AN/A
2023-09-30$0.00N/AN/A
2022-09-30$0.00N/AN/A

1 of 1

Citius Oncology Revenue FAQ

What was CTOR's revenue last quarter?

Citius Oncology (NASDAQ: CTOR) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Citius Oncology's revenue was $0.00.

What was Citius Oncology's revenue in 2024?

Citius Oncology's annual revenue for the twelve months ending Sep 30, 2024 was $0.00, a N/A decrease year over year.

How much does Citius Oncology make in a day?

Based on Citius Oncology annual revenue for the past two years, CTOR makes an average of $0.00 per day.

What was Citius Oncology's annual revenue growth in the past year?

As of Q1 2025, Citius Oncology's revenue has grown null year over year. Citius Oncology's revenue in the past year totaled $0.00.

How much does Citius Oncology make in a year?

Citius Oncology's revenue by year for the past two years is:
  • Citius Oncology's revenue for the twelve months ending Sep 30, 2024 was $0.00, a N/A decrease year over year.
  • Citius Oncology's annual revenue for Sep 30, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.